Jump to Main Content
- Kumar Pal, Dilip, et al. Show all 48 Authors
- Vaccine 2017 v.35 no.45 pp. 6228-6237
- Rotavirus; children; clinical trials; diarrhea; gastroenteritis; infants; monitoring; morbidity; mortality; oral administration; vaccination; vaccines; India
- ... Rotavirus is the most common cause of moderate-to-severe infant diarrhoea in developing countries, resulting in enormous morbidity, mortality, and economic burden. A bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV) targeting the globally most common strains was developed in India and tested in a randomized, double-blind, placebo-controlled end-point driven Phase III efficacy clinica ...
- PubMed Central: